Samuel T. Wilkinson

Sep 25, 2024 | ifstudies.org | Wendy Wang |Samuel T. Wilkinson

America is facing a mental health crisis. Suicide, anxiety, depression, and drug overdose deaths have all risen to record levels. Younger generations have been hit especially hard during this crisis. Millennial men and women experience increased anxiety and depression compared to previous generations at the same age. Some argue that the emotional state of young adults today is related to their financial precarity.

Jul 2, 2024 | psychologytoday.com | Samuel T. Wilkinson

The tension between our need to achieve and the happiness that comes from cultivating strong relationships often leaves us unsure of where we should direct our resources.

Jan 3, 2024 | jamanetwork.com | Samuel T. Wilkinson |Joseph Palamar |Gerard Sanacora

The Rapidly Shifting Ketamine Landscape in the US In recent years, ketamine has been hailed as a miracle treatment for depression and related disorders. The US Food and Drug Administration (FDA) approved the S-enantiomer of ketamine, esketamine, as the first antidepressant in a new class for treatment-resistant depression in 2019.1 Emerging evidence suggests that the landscape of ketamine both as a medical therapeutic and as a recreational substance is shifting.